MRES (Institute of Biomedical Research) Total Liabilities: $0.46 Mil (As of Dec. 2010)


What is Institute of Biomedical Research Total Liabilities?

Institute of Biomedical Research MRES -14.62% Total Liabilities is $0.46 Mil as of Dec. 2010.

Institute of Biomedical Research's Total Liabilities for the quarter that ended in Dec. 2010 was $0.46 Mil.

Institute of Biomedical Research's quarterly Total Liabilities increased from Jun. 2010 ($1.59 Mil) to Sep. 2010 ($1.65 Mil) but then declined from Sep. 2010 ($1.65 Mil) to Dec. 2010 ($0.46 Mil).

Institute of Biomedical Research's annual Total Liabilities declined from Mar. 2008 ($0.19 Mil) to Mar. 2009 ($0.15 Mil) but then increased from Mar. 2009 ($0.15 Mil) to Mar. 2010 ($0.42 Mil).

Institute of Biomedical Research Total Liabilities Historical Data

* Premium members only.

The historical data trend for Institute of Biomedical Research's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Institute of Biomedical Research Total Liabilities Chart

Institute of Biomedical Research Annual Data
Trend Dec03 Dec04 Mar06 Mar07 Mar08 Mar09 Mar10
Total Liabilities
Get a 7-Day Free Trial 0.23 0.02 0.19 0.15 0.42

Institute of Biomedical Research Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.42 1.59 1.65 0.46

Institute of Biomedical Research Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Institute of Biomedical Research's Total Liabilities for the fiscal year that ended in Mar. 2010 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.422+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.42

Total Liabilities=Total Assets (A: Mar. 2010 )-Total Equity (A: Mar. 2010 )
=0.076--0.345
=0.42

Institute of Biomedical Research's Total Liabilities for the quarter that ended in Dec. 2010 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.461+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.46

Total Liabilities=Total Assets (Q: Dec. 2010 )-Total Equity (Q: Dec. 2010 )
=0.655-0.193
=0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $0.46 Mil mean?
Institute of Biomedical Research (MRES) has a Total Liabilities of $0.46 Mil as of Dec. 2010. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Institute of Biomedical Research and its competitors.
Is Institute of Biomedical Research's Total Liabilities too high?
Institute of Biomedical Research's current Total Liabilities is $0.46 Mil.
How does Institute of Biomedical Research's Total Liabilities compare to HSTC and NTRR?
Institute of Biomedical Research's Total Liabilities of $0.46 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Institute of Biomedical Research and its competitors. Institute of Biomedical Research's current Total Liabilities is $0.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Institute of Biomedical Research stock overvalued right now?
Institute of Biomedical Research (MRES) has a current Total Liabilities of $0.46 Mil. The current Total Liabilities is $0.46 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Institute of Biomedical Research (MRES), the current Total Liabilities is $0.46 Mil as of Dec. 2010. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Institute of Biomedical Research Business Description

Address Dubai Science Park, 13th Floor, South Tower, Dubai, ARE, 416452
Institute of Biomedical Research Corp is a biomedical research and development company. The company is focused on alternative plant-based food and medicine and mental health therapeutic research. The company uses brand name M2Bio Sciences engaged in deploying artificial intelligence, science and medicine, clinical research, and emerging technologies.